Yot is a medical doctor and health economist by training. He found the Thai Ministry of Public Health’s Health Intervention and Technology Assessment Program (HITAP) before joining the Saw Swee Hock School of Public Health at the National University of Singapore as a Visiting Professor. He is also a co-founder of the HTAsiaLink and the international Decision Support Initiative (iDSI). His works have been used to inform health benefits packages in Thailand and elsewhere across the globe. He has provided capacity building in health technology assessment and health economic evaluations in Bhutan, China, Ethiopia, Ghana, India, Indonesia, Japan, Kenya, Korea, Laos, Myanmar, Nepal, the Philippines, South Africa, Sri Lanka, Tanzania, Timor-Leste, and Vietnam.

• NUS Saw Swee Hock School of Public Health (Visiting)
• Health Intervention and Technology Assessment Program, Ministry of Health, Thailand (Primary)
• Non-resident Fellow, Center for Global Development, 2020 -present (Adjunct)

• Health economic evaluation
• Health technology assessment
• Health services research

• Cost-effectiveness analysis
• Impact evaluation

• Doctor of Philosophy in Health Economics, University of East Anglia, England, 2006
• Postgraduate Diploma in Health Sciences, University of East Anglia, 2003
• Doctor of Medicine, Chulalongkorn University, 1997

• The Thailand Research Fund’s Outstanding Researcher of the Year in 2015
• The Thailand’s Ministry of Public Health’s the Best Research Award in Year 2008 (for non-clinical study)
• The Best Research Award, the Third National Alcohol Conference, Bangkok, 2007
• The Best Podium Presentation, 2nd Asia-Pacific ISPOR conference, Shanghai, 2006

• General Secretary of HITAP Foundation, 2010-present
• Visiting Professor, Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore, 2018-present
• Non-resident Fellow, Center for Global Development, 2020-present
• Founding member of the executive board of international Decision Support Initiative (iDSI), 2015- present
• Senior Research Scholar of Thailand Research Fund on Health Technology Assessment, 2012-2019
• Secretary General of the National Health Foundation, 2019-2020
• Researcher, International Health Policy Program (IHPP), May 2001-Dec 2006
• Research Fellow, Senior Research Scholar Program in Health Financing and Health Economics, Health Systems Research Institute, January 2000-April 2001
• Hospital Director, Pong Hospital, Phayao Province, June1998-January 2000

• Founding Leader of the HITAP, January 2007-2017
• Secretary General of the National Health Foundation, 2019-2020
• Hospital Director, Pong Hospital, Phayao Province, 1998-2000

• Member of the Review Sub-Committee for the COVID-19 Stimulus and Relief Packages ($32 billion) of the Royal Thai government (May 2020 -present)
• Member of the Working Group on Situation Analysis and Academic support of the Thai MOPH Center for Policy Responses on Public Health Emergency on COVID-19 Pandemic in Thailand (April 2020 -present)
• Member of the WHO’s Working Group to develop the WHO Target Product Profiles for COVID-19 Vaccines (March – April 2020)
• Member of the National Committee for Monitoring and Evaluation of the Thailand Science Research and Innovation Fund (Jan 2020-present)
• Member of the International Organizing Committee of Prince Mahidol Award Conference 2015-present
• Member of the National Committee for Development of the Thailand’s Pharmaceutical Reimbursement List, 2007-present
• Elected board member of HTAsiaLink executive board, 2016-present
• President of HTAsiaLink, a regional network of 30 HTA agencies in Asia and Pacific region, 2012-2013 & 2017-2018
• Member of the World Health Organization’s Scientific Advisory Group for the Blueprint on Research and Development Preparedness 2017-2019
• Member of the World Health Organization’s Immunization and Vaccines related-Implementation Research Advisory Committee (IVIR-AC), 2014-2019
• Member of the Advisory Committee of the National Science and Technology Development Agency on Hospital Practice & Medical Devices, 2011-2015
• Vice Chair of Health Economic Working Group for the National Committee for Development of the Thailand’s Pharmaceutical Reimbursement List, 2013-2016
• Scientific Advisory Committee member of Prince Mahidol Award Foundation under Royal Patronage, 2013-2015
• Member of the Mid-term Review of Disease Control Priority Network, 2014
• Associate editor of BMC Health Services Research, 2009-2014

• Teerawattananon Y, Dabak SV. COVID vaccination logistics: five steps to take now. Nature. 2020 Nov;587(7833):194-196. doi:10.1038/d41586-020-03134-2
• Ravindran TS, Teerawattananon Y, Tannenbaum C, Vijayasingham L. Making pharmaceutical research and regulation work for women. BMJ. 2020 Oct 27;371:m3808. doi:10.1136/bmj.m3808.
• Teerawattananon Y, Tungsanga K, Hakiba S, Dabak S. Dispelling the myths of providing dialysis in low- and middle-income countries. Nat Rev Nephrol. 2020 Aug 19:1-2. doi:10.1038/s41581-020-00346-7.
• Teerawattananon Y, Dabak SV, Khoe LC, Bayani DBS, Isaranuwatchai W. To include or not include: renal dialysis policy in the era of universal health coverage. BMJ. 2020;368:m82.
• Isaranuwatchai W, Teerawattananon Y, Archer RA, et al. Prevention of non-communicable disease: best buys, wasted buys, and contestable buys. BMJ. 2020;368:m141.
• Teerawattananon Y, Luz AC, Culyer A, Chalkidou K. Charging for the use of survey instruments on population health: the case of quality-adjusted life years. Bull World Health Organ. 2020 Jan 1;98(1):59-65.
• Teerawattananon Y, Luz K, Yothasmutra C, Pwu RF, Ahn J, Shafie AA, et al. Historical development of the HTAsiaLink network and its key determinants of success. International journal of technology assessment in health care. 2018;34(3):260-6.
• Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H. Essential medicines for universal health coverage. The Lancet. 2017 Jan 28;389(10067):403-76.
• Teerawattananon Y, Kingkaew P, Koopitakkajorn T, Youngkong S, Tritasavit N, Srisuwan P, et al. Development of a Health Screening Package Under the Universal Health Coverage: The Role of Health Technology Assessment. Health economics. 2016;25 Suppl 1:162-78.
• Teerawattananon Y, Tritasavit N. A learning experience from price negotiations for vaccines. Vaccine. 2015;33 Suppl 1:A11-2.

View his publications on Google Scholar and Scopus.